Chromium picolinate therapy in pre/diabetes care: recognition of individual risks and outcomes

Documenti analoghi

• Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics
  di: Yeghiazaryan, Kristina, et al.
  Pubblicazione: (2012)
• Chromium-picolinate therapy in diabetes care: molecular and subcellular profiling revealed a necessity for individual outcome prediction, personalised treatment algorithms & new guidelines
  di: Yeghiazaryan, Kristina, et al.
  Pubblicazione: (2011)
• Opinion controversy to chromium picolinate therapy’s safety and efficacy: ignoring ‘anecdotes’ of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?
  di: Golubnitschaja, Olga, et al.
  Pubblicazione: (2012)
• “Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
  di: Golubnitschaja, Olga, et al.
  Pubblicazione: (2014)
• Paradigm change to cost-effective predictive and preventive medicine: individual profiling of healthy vasospastic individuals for targeted prevention as the cost-effective personalised medicine
  di: Golubnitschaja, Olga, et al.
  Pubblicazione: (2014)